4.5 Article

Characterization of anti-self CD8 T-cell responses stimulated by recombinant Listeria monocytogenes expressing the melanoma antigen TRP-2

Journal

VACCINE
Volume 23, Issue 33, Pages 4263-4272

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2005.02.018

Keywords

Listeria monocytogenes; vaccination; tumor immunity

Funding

  1. NCI NIH HHS [R01 CA127565, R01 CA84008-01] Funding Source: Medline
  2. NIGMS NIH HHS [GM07104] Funding Source: Medline

Ask authors/readers for more resources

A potential approach to activate tumor-specific T cells is to use live bacterial vectors to deliver appropriate antigens in a highly immunostimulatory context. We constructed a recombinant strain of Listeria monocytogenes (rLM) expressing murine tyrosinase-related protein-2 (TRP-2). a nonmutated melanocyte-derived differentiation antigen highly expressed in melanomas. Immunization of C57B1/6 mice with this rLM strain efficiently primed CD8 T cells to recognize the MHC class I-restricted TRP-2(180-188) epitope and express IFN-gamma upon in vitro peptide stimulation. Peptide-loaded target cells were lysed in vitro by TRP-2-specific T cells in cytotoxicity assays, and mice immunized and boosted with rLM expressing TRP-2 were functionally protected from subcutaneous challenge with B 16 melanoma cells. These results identify and characterize the anti-self T-cell responses induced by recombinant L. monocytogenes expressing an endogenous, nonmutated tumor antigen. (c) 2005 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available